trial · primary record
Standard dose rifampicin
Tuberculosis Infection
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-10-31 |
| Primary endpoint | Area under the concentration-time curve from 0 to 24 hours (AUC0-24) |
| Registry ID | NCT07069582 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:37.721Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07069582
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.